María Natalia Gandur Quiroga, MD, MSc

Articles by María Natalia Gandur Quiroga, MD, MSc

EV plus pembro approval reframes first conversation in MIBC diagnosis

July 13th 2026

Enfortumab vedotin-ejfv (Padcev) plus pembrolizumab's (Keytruda) expanded approval shifts the perioperative MIBC conversation from cisplatin eligibility to optimal systemic strategy, according to María Natalia Gandur Quiroga, MD, MSc.

Latest Updated Articles

Trending on Urology Times

FDA approves enfortumab vedotin plus pembrolizumab for MIBC

The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS

Amy E. Krambeck, MD, on choosing between CVAC and FANS for suction-based ureteroscopy

Trial launches of actinium (225Ac) rhPSMA-10.1 injection in mCRPC

Study suggests tamsulosin deprescribing may be appropriate for select men with BPH